| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.408 | 16.833 | 18.924 | 14.706 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 26.408 | 16.841 | 18.924 | 14.706 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 23.488 | 19.831 | 15.138 | 11.806 | 84 | 94 | 6.225 | 3 | 4 | 5 |
| Gross Profit/Loss - EUR | 2.920 | -2.990 | 3.786 | 2.900 | -84 | -94 | -6.225 | -3 | -4 | -5 |
| Net Profit/Loss - EUR | 2.129 | -3.327 | 3.597 | 2.753 | -84 | -94 | -6.225 | -3 | -4 | -5 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Vidamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 438 | 540 | 387 | 259 | 173 | 97 | 0 | 0 | 0 | 0 |
| Current Assets | 8.432 | 7.471 | 8.725 | 6.466 | 6.341 | 6.221 | 0 | 0 | 0 | 0 |
| Inventories | 8.156 | 7.340 | 8.544 | 6.466 | 6.341 | 6.221 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 276 | 132 | 181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -1.748 | -5.057 | -1.375 | 1.403 | 1.292 | 1.173 | -5.078 | -5.097 | -5.086 | -5.062 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.618 | 13.069 | 10.487 | 5.322 | 5.222 | 5.144 | 5.078 | 5.097 | 5.086 | 5.062 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Bio Vidamed Srl